|
1. |
Comparison between Clinician-Rated and Self-Reported Depressive Symptoms in Italian Psychiatric Patients |
|
Neuropsychobiology,
Volume 19,
Issue 1,
1988,
Page 1-5
Leonardo Tondo,
Caterina Burrai,
Luciana Scamonatti,
Jan Weissenburger,
John Rush,
Preview
|
PDF (1089KB)
|
|
摘要:
The Inventory for Depressive Symptomatology is a new scale for measuring depressive symptoms. The reliability, validity and correlations between self-report and clinician-rated versions of the scale were examined in 86 Italian psychiatric patients. Results confirmed the validity and internal consistency of the scales. Self-ratings and clinician ratings were highly correlated. Total score on the self-rating scale was generally higher than the corresponding clinician scale score. Item analysis revealed that most items were rated slightly higher by self-report, with the items contributing most to this discrepancy being psychomotor agitation and retardation, self-outlook, and irritable mood. Both quality of mood and psychomotor agitation were more frequently endorsed by self-report than by clinician rating.
ISSN:0302-282X
DOI:10.1159/000118423
出版商:S. Karger AG
年代:1988
数据来源: Karger
|
2. |
Sydenham’s Chorea and Psychopathology |
|
Neuropsychobiology,
Volume 19,
Issue 1,
1988,
Page 6-8
Allen Wilcox,
Henry Nasrallah,
Preview
|
PDF (593KB)
|
|
摘要:
Sydenham’s chorea is a movement disorder seen in rheumatic fever with basal ganglia pathology. This disorder has been associated with an increased frequency of psychopathology in both the acute choreiform stage and later in life. We conducted a prospective study of 29 subjects with Sydenham’s chorea and 29 age- and sex-matched controls. The total number of psychiatric symptoms 10 years after the initial contact was much greater in the study group than in controls (p < 0.001). Similarly, schizophrenia was more common in the study group compared to controls (p < 0.01). Possible neuropathological associations and treatment are discus
ISSN:0302-282X
DOI:10.1159/000118424
出版商:S. Karger AG
年代:1988
数据来源: Karger
|
3. |
Diurnal and Circannual Variation in Platelet3H-Imipramine Binding: Comparative Data on Normal and Affectively Ill Subjects |
|
Neuropsychobiology,
Volume 19,
Issue 1,
1988,
Page 9-11
Miron Baron,
Amiram Barkai,
Sharon Kowalik,
Ronald R. Fieve,
Frederic Quitkin,
Rhoda Gruen,
Preview
|
PDF (634KB)
|
|
摘要:
Using a cross-sectional design, we examined the diurnal and circannual variation in platelet 3H-imipramine binding in 33 patients with bipolar affective disorder, 34 patients with unipolar affective disorder and 58 normal controls. There was no evidence for statistically significant diurnal or circannual variation in the binding parameters in any of the diagnostic categories.
ISSN:0302-282X
DOI:10.1159/000118425
出版商:S. Karger AG
年代:1988
数据来源: Karger
|
4. |
Individuality and Stability in the Transport of Precursors of Monoamines across the Erythrocyte Membrane of Mentally Normal Subjects |
|
Neuropsychobiology,
Volume 19,
Issue 1,
1988,
Page 12-16
P. Schulz,
Thee Bugman,
J. Widmer,
P. Dick,
R. Tissot,
Preview
|
PDF (745KB)
|
|
摘要:
We evaluated to what extent the tyrosine (TYR) and tryptophan (TRP) transport by the red cells was stable in normal subjects during divers clinical conditions. Twenty-two normal subjects were studied. The values of TYR and TRP transport were found to be individually determined, showed no circadian oscillations and no changes during the menstrual cycle, but varied somewhat more during the postpartum period. A few normal subjects had low TYR and TRP transport values, as observed in patients with affective disorders.
ISSN:0302-282X
DOI:10.1159/000118426
出版商:S. Karger AG
年代:1988
数据来源: Karger
|
5. |
Alternate-Day Corticosteroid Treatment, Mood and Plasma HVA in Patients with Systemic Lupus erythematosus |
|
Neuropsychobiology,
Volume 19,
Issue 1,
1988,
Page 17-19
Russell T. Joffe,
Owen M. Wolkowitz,
David R. Rubinow,
Kirk Denicoff,
George Tsokos,
Stanley Pillemer,
Preview
|
PDF (497KB)
|
|
摘要:
Corticosteroid therapy may produce alterations in mood. Furthermore, several monoamines, including dopamine, have been implicated in the regulation of mood. We, therefore, examined the relationship between alterations in mood and plasma homovanillic acid (HVA) levels in patients on alternate-day corticosteroid treatment. Although several patients had substantial alterations in mood, there was no significant difference in plasma HVA levels between the on- and off-medication day. Furthermore alterations in depression and anxiety levels were not related to plasma HVA levels. The implications of these findings are discussed.
ISSN:0302-282X
DOI:10.1159/000118427
出版商:S. Karger AG
年代:1988
数据来源: Karger
|
6. |
Therapeutic Effect of Maprotiline and Chlorimipramine: Controlled Study |
|
Neuropsychobiology,
Volume 19,
Issue 1,
1988,
Page 20-24
M.L. Montejo-Iglesias,
J.A. Ramos-Brieva,
Preview
|
PDF (1009KB)
|
|
摘要:
A study was done on 40 outpatients suffering from major affective disorders (uni- and bipolar). Chlorimipramine or maprotiline was administered alternatively (x = 116.25 and 116.75 mg/day, respectively). The therapeutic effect of both antidepressive drugs is very similar, but maprotiline improves the gastrointestinal somatic symptoms faster and seems to be more effective in bipolar patients. It also produces less side effects than chlorimipramine.
ISSN:0302-282X
DOI:10.1159/000118428
出版商:S. Karger AG
年代:1988
数据来源: Karger
|
7. |
A Double-Blind Randomized Study of Clomipramine versus Maprotiline in Patients with Idiopathic Pain Syndromes |
|
Neuropsychobiology,
Volume 19,
Issue 1,
1988,
Page 25-34
G. Eberhard,
L. von Knorring,
H.L. Nilsson,
U. Sundequist,
G. Björling,
H. Under,
K.O. Svärd,
L. Tysk,
Preview
|
PDF (2074KB)
|
|
摘要:
Seventy patients with idiopathic syndromes were treated with maprotiline, a noradrenaline reuptake inhibitor, or clomipramine, a serotonin reuptake inhibitor in a 6-week, double-blind, randomized, multicenter trial. Fifty-two patients completed the double-blind phase. Overall, 50% of the patients improved. Significant decreases were seen not only in the levels of pain but also in bodily discomfort, sadness and inner tension (determined by visual analogue scales, VAS). A decrease was also found in the frequency of sleep disturbances, intellectual and emotional inhibition, irritability, guilt feelings, retardation, sadness and suicidal ideas (observed ratings). Sixty-three percent of the subjects showed an overall improvement during treatment with clomipramine as compared to 36% during treatment with maprotiline (p < 0.05). During clomipramine treatment significant decreases were seen on all the six VAS: sadness, bodily discomfort, inner tension, concentration difficulties, memory disturbances and pain. Bodily discomfort and pain were significantly reduced during maprotiline treatment. The effects produced by clomipramine were also significantly greater than the effects caused by maprotiline as concerns psychic anxiety and inhibition (VAS). The overall reduction in VAS was significantly greater with clomipramine when compared to maprotiline. The most important side effects were dry mouth (both drugs) and sweating (clomipramine). However, in the clomipramine group, 8 patients were excluded due to side effects as compared to 1 patient in the maprotiline group. Thus, the results indicate that antidepressants reduce not only pain but are also of clinical value in the treatment of patients with idiopathic pain syndromes. Drugs with pronounced effects on the serotonin reuptake are to be preferred.
ISSN:0302-282X
DOI:10.1159/000118429
出版商:S. Karger AG
年代:1988
数据来源: Karger
|
8. |
The Cholinergic Agonist RS 86:a Pharmacopsychological Study |
|
Neuropsychobiology,
Volume 19,
Issue 1,
1988,
Page 35-39
Juergen Fritze,
Helmut Beckmann,
Preview
|
PDF (1039KB)
|
|
摘要:
The cholinergic-adrenergic balance hypothesis of affective disorders postulates noradrenergic overactivity and cholinergic hypoactivity in mania and the converse in depression. Some evidence for cholinergic contributions to mood regulation derives from the antimanic and depressiogenic activity of physostigmine and arecoline. However, both drugs have pharmacodynamic and pharmacokinetic disadvantages. Therefore, the orally active muscarinic agonist RS 86 was tested in a double-blind dose-response study for its psychotropic effects in one healthy volunteer. A dose-dependent anergic-anhedonic syndrome was identified in comparison to placebo. The study confirms the physostigmine syndrome to be mediated by muscarinic, possibly Ml receptors, and gives further support to the hypothesis of a cholinergic modulation of mood and behavior in man.
ISSN:0302-282X
DOI:10.1159/000118430
出版商:S. Karger AG
年代:1988
数据来源: Karger
|
9. |
Psychotropic Effects of Corticotropin-Releasing Hormone Stimulation in Depressive Patients |
|
Neuropsychobiology,
Volume 19,
Issue 1,
1988,
Page 40-44
G. Laux,
K.-P. Lesch,
M. Schwab,
Preview
|
PDF (769KB)
|
|
摘要:
Synthetic human corticotropin-releasing hormone (hCRH) was administered as an intravenous bolus (100 µg) to 13 patients suffering from endogenous depression and to 12 healthy volunteers. Compared with controls, depressed patients showed a significant amelioration of mood and well-being 2 h after hCRH administration in the rating scales applied (‘Befindlichkeits-Skala’, &Egr;igenschaftswörterliste’, ‘Kurzskala Stimmung-Aktivierung’, Self-Rating Depression Scale, Hamilton Rating Scale for Depression). Based on our preliminary data, a psychotropic effect and at least a mediating function of hCRH regarding pathophysiology and etiopathogenesis of endogenous depressions must
ISSN:0302-282X
DOI:10.1159/000118431
出版商:S. Karger AG
年代:1988
数据来源: Karger
|
10. |
Cognitive Training Adjunctive to Pharmacotherapy in Schizophrenia and Depression: A Pilot Study on the Lateralization Hypothesis of Schizophrenia and Depression and on Cognitive Therapy as Adjunctive to Pharmacotherapy |
|
Neuropsychobiology,
Volume 19,
Issue 1,
1988,
Page 45-50
J. Fritze,
B. Förthner,
B. Schmitt,
U. Thaler,
Preview
|
PDF (1158KB)
|
|
摘要:
Although controversial, evidence from various experimental sources suggests a dysfunction/overactivity of the hemisphere dominant for speech – usually the left – in schizophrenia and of the other one in depression. Based on these lateralization hypotheses and on the dependency of regional cerebral blood flow on regional neuronal activity, the concept of pharmacopsychotherapy was proposed. The present double-blind pilot study tried to test this concept by cognitive training procedures tentatively relevant to the mechanisms of information processing of the left (analytical) and right (holistic) hemisphere, respectively. It was hypothesized that the outcome of patients putatively trained in mechanisms of the right hemisphere might be superior to that of those trained left in depression and the converse in schizophrenia. This hypothesis could not be verified. Apparent differences in the outcome of depressives were attributable to differences of independent variables (age, seriousness of illne
ISSN:0302-282X
DOI:10.1159/000118432
出版商:S. Karger AG
年代:1988
数据来源: Karger
|
|